Artificial pancreas clinical trials: Moving towards closed-loop control using insulin-on-board constraints

Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart insulinpump with a Continuous Glucose Monitor (CGM) and a control algorithm to improve the regulation ofglycaemia. Based on the extensive clinical evidence provided by the main research groups in the a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fushimi, Emilia, Rosales, Nicolás, De Battista, Hernán, Garelli, Fabricio
Formato: Articulo
Lenguaje:Inglés
Publicado: 2018
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/149290
Aporte de:

Ejemplares similares